Tacalyx
Business Services · Germany · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Magnusstrasse 11, Berlin, Berlin, 12489,...Phone Number
+49 3040723710Website
www.tacalyx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Tacalyx
Tacalyx GmbH, founded in 2019 as a spin-out from the Max-Planck-Institute, focuses on developing innovative anticancer therapeutics that target Tumor Associated Carbohydrate Antigens (TACAs). The company aims to create first-in-class assets for various solid human cancers, utilizing treatment modalities such as antibody-drug conjugates and T cell engagers. Their intended clients include healthcare providers and researchers in the oncology field. Located in Berlin, Tacalyx fosters a vibrant research environment for motivated scientists dedicated to advancing antibody drug development.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tacalyx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Tacalyx had a recent Job posting/layoffs
Tacalyx, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Tacalyx has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Tacalyx has new funding data
Check out if Tacalyx is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Tacalyx recently announced quarterly report
Product Launch: Get notified when Tacalyx launches new products
Congratulate Masked Content for being promoted to Masked Content at Tacalyx
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Tacalyx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tacalyx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tacalyx.
Tacalyx financials insights
Gather financial insights about Tacalyx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$15M
2026
Other Financing Round
$12.8M
Tacalyx Tech Stack
A closer look at the technologies used by Tacalyx
Most Recent Scoops
Funding
Funding
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Tacalyx News & Media
Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic
Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the ClinicTacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth
Berlin, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tacalyx, a privately held biotech company focused on developing novel TACA (Tumour Associated Carbohydrate Antigens) cancer therapies, announces the appointment of Jean Engela as Chief Executive Officer. Jean Engela brings more than two decades of experience in drug research and development, with a proven track record of leading organisations and assets through key phase transitions and scaling from discovery to clinical stages. The company’s co
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tacalyx
Sign Up For FreeTo access detailed company insights
Tacalyx GmbH, founded in 2019 as a spin-out from the Max-Planck-Institute, focuses on developing innovative anticancer therapeutics that target Tumor Associated Carbohydrate Antigens (TACAs). The company aims to create first-in-class assets for various solid human cancers, utilizing treatment modalities such as antibody-drug conjugates and T cell e... Read More
